Clinical Trial Update: PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PG2 Injection evaluating treatment of cancer-related fatigue in breast cancer patients; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer-related Fatigue

Drugs mentioned

• PG2 Injection (PG2)

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer-related Fatigue | Phase 2 | Status: RECRUITING